These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3873901)
1. In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics. Matsuhashi Y; Yoshida T; Hara T; Kazuno Y; Inouye S Antimicrob Agents Chemother; 1985 Apr; 27(4):589-94. PubMed ID: 3873901 [TBL] [Abstract][Full Text] [Related]
2. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria. Omoto S; Yoshida T; Kurebe M; Inouye S Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides. Gu JW; Neu HC Antimicrob Agents Chemother; 1989 Nov; 33(11):1998-2003. PubMed ID: 2514625 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes. Felmingham D; Jones K Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin. Inouye S; Hara T; Matsuhashi Y; Kitasato I Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214 [TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals. Inouye S; Niizato T; Shomura T; Kitasato I Drugs Exp Clin Res; 1989; 15(5):189-209. PubMed ID: 2791871 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside. Saino Y; Hattori Y; Koshi T; Kobayashi F; Oda T; Mitsuhashi S Antimicrob Agents Chemother; 1984 Aug; 26(2):187-91. PubMed ID: 6548350 [TBL] [Abstract][Full Text] [Related]
8. Stability of dactimicin to aminoglycoside-modifying enzymes. Gomez-Lus R; Marco MA; Gomez-Lus ML Drugs Exp Clin Res; 1987; 13(12):731-5. PubMed ID: 3447876 [TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia]. Kettner M; Miller GH; Inouye S Bratisl Lek Listy; 1992 Mar; 93(3):131-5. PubMed ID: 1525686 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic. Ohashi Y; Kawabe H; Sato K; Nakamura N; Kurashige S; Mitsuhashi S Antimicrob Agents Chemother; 1980 Feb; 17(2):138-43. PubMed ID: 7387138 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside. Kobayashi F; Saino Y; Koshi T; Hattori Y Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599 [TBL] [Abstract][Full Text] [Related]
12. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics. Paglia P; Molinari G; Pesce A; Debbia EA Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028 [TBL] [Abstract][Full Text] [Related]
13. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Kabins SA; Nathan C; Cohen S Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats. Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879 [TBL] [Abstract][Full Text] [Related]
15. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic. Stefani S; Nicoletti G; Russo G; Toscano MA Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875 [TBL] [Abstract][Full Text] [Related]
16. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria. Stefani S; Debbia EA; Schito GC; Russo G Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of clinical isolates to dactimicin and gentamicin. Bergan T Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907 [TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410 [TBL] [Abstract][Full Text] [Related]
20. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics. Debbia EA; Schito GC; Stefani S; Nicoletti G Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]